Credit Suisse analyst Trung Huynh combed through social media comments about Eli Lilly's Mounjaro and has some key takeaways.
You can't deny the buzz. Credit Suisse analyst Trung Huynh has combed through social media and is impressed by the awareness — and demand — for GLP-1 medications such as Eli Lilly 's Mounjaro.
Others taking the drug reported benefits such as a reduction in addiction behaviors such as smoking, drinking, gambling and shopping, among other things. "Although relatively unsurprising given the literature suggests GLP agonism suppresses hedonic food intake through the brain reward pathway, we are very interested in the potentially far-reaching effect beyond obesity and T2D," Huynh said.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Eli Lilly CEO says Medicare price negotiations could harm drug developmentRicks said the 'biggest problem' with the IRA provision stems from a difference in timeline for negotiating prices on two different types of drugs.
Leer más »
EUR/GBP target lowered to 0.8450 and GBP/USD target raised to 1.2800 – Credit SuisseOne of Credit Suisse’s most consistent views over the course of 2023 has been GBP bullishness. Economists at the bank take a fresh look at the Pound.
Leer más »
Fed Preview: Three scenarios and their implications for the US Dollar Credit SuisseEconomists at Credit Suisse discuss the Federal Reserve interest rate decision and its implications for the US Dollar. Fed surprises with a 25 bps hik
Leer más »
Ignore the misinformation: The Credit Card Competition Act would benefit businesses, consumers, and credit unionsPromoting misleading messaging to push a political agenda is not a new tactic. However, it is still disheartening to see how misstatements, half-truths, and outright lies are being weaponized to oppose a policy that could genuinely benefit consumers and small businesses.
Leer más »
Vast utility for weight loss drugs will more than pay for themselves, says Eli Lilly CEO David RicksEli Lilly CEO David Ricks joins CNBC's Bertha Coombs and 'The Exchange' live from the World Medical Innovation Forum to discuss Eli Lilly's alzheimer's treatment, concerns over coverage reimbursement schemes, and upcoming drug price negotiations.
Leer más »
“I Would Love to Be at a Fashion House”—Eli Russell Linnetz on ERL’s First IRL Show and His Move From Venice to FlorenceTake an exclusive first look into Eli Russel Linnetz’s first IRL show at Pitti Uomo:
Leer más »